Testing the Addition of AZD6738 (Ceralasertib) to Immunotherapy to Increase Time Without Cancer for Patients With Non-Small Cell Lung Cancer

NCT06732401 · clinicaltrials.gov ↗

PHASE3

Phase

ACTIVE_NOT_RECRUITING

Status

630

Enrollment

NIH

Sponsor class

Conditions

Lung Non-Small Cell Carcinoma
Stage II Lung Cancer AJCC v8
Stage IIIA Lung Cancer AJCC v8
Stage IIIB Lung Cancer AJCC v8

Interventions

PROCEDURE: Biospecimen Collection
DRUG: Ceralasertib
PROCEDURE: Computed Tomography
BIOLOGICAL: Durvalumab
PROCEDURE: Echocardiography Test

Sponsor

National Cancer Institute (NCI)